Hopman Mark sold BBNX
December 4, 2025 · Form 4 insider transaction
Hopman Mark sold 2,061 shares of Beta Bionics, Inc. at $30.66 per share, a transaction worth $63.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 102 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,061
Price
$30.66
Total value
$63.2K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 4, 2025
Filing dateMarch 16, 2026
Shares owned after136,216
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.; The weighted average sale price for the transaction reported was $30.6610 and the range of prices were between $30.02 and $31.0024. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.